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1. Introduction
  Sourced from “Renewed Popular Treatise on Febrile 
Diseases”  Haoqinqingdan decoction is a famous 
prescription founded by Gen-Chu Yu, a famous doctor in 
Qing dynasty[1]. This prescription was designed originally 
for Shaoyang damp-heat syndrome and proved to have good 
efficacy in clinical practice[2]. The damp-heat syndrome is 
an acute exogenous febrile disease caused by pathogenic 
dampness. The causes of damp-heat syndrome are 
multifactorial, including not only environmental factors, but 
also autoimmune function and pathogenic microorganism[3]. 
Viral infection is one of the common causes of damp-
heat syndrome. It was found that people tend to have viral 
damp-heat syndrome in hot and humid environment, and 
Objective: To investigate the effect of Chinese medicine prescription-Haoqinqingdan decoction 
on damp-heat syndrome in rats with influenza viral pneumonia and its influence on the immune 
function. Methods: A total of 48 Wistar rats were randomly divided into the normal control 
group, the damp-heat syndrome model group, the Haoqinqingdan decoction group (high, medium 
and low dose group) and the ribavirin group. The body temperature and weight of rats in each 
group were recorded after modeling. After treatment for 6 d, the concentration of T lymphocyte 
subgroup (CD3+CD4+, CD3+CD8+) was determined by flow cytometry. The OD value of IFN-毭/IL-4 
was detected by double-antibody sandwich ELISA method, and its concentration was acquired 
through conversion. Results: After modeling, the temperature and weight of rats in each modeling 
group showed the increasing trend (P<0.01). From the second day of treatment, there was 
significant difference in the body mass between groups, and the rat weight of the control group 
was higher than in the modeling group (P<0.05 or 0.01). With the advances of treatment, only the 
temperature in the medium and high dose Haoqinqingdan decoction groups declined significantly 
(P<0.05). After treatment, the CD4+/CD8+ ratio of the damp-heat syndrome model group decreased 
more significantly compared with the control group. Elevated CD3+CD8+ percentages and declined 
CD4
+/CD8+ ratios can be observed in the low dose group and ribavirin group (P<0.05). Moreover, 
the CD3+CD4+ percentage of ribavirin group was lower than in the control group (P<0.05). After 
treatment, the IFN-毭 and IFN-毭/ IL-4 levels in the peripheral blood of rats in the damp-
heat syndrome group were obviously higher than in the control group (P<0.05). Conclusions: 
Compared with ribavirin, the high dose Haoqinqingdan decoction can improve the ratio of T 
lymphocyte subgroup and Th1/Th2 cell balance more effectively.
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influenza virus infection is most common[4]. Due to the 
limitation of Western medicine and the hysteresis of vaccine 
development, the treatment of this disease is not satisfactory. 
However, traditional Chinese medicine shows its unique 
advantages in the treatment of this disease. A study found 
that Haoqinqingdan decoction can decrease the mRNA 
level of NF-毷 B and the percentage of Th1/Th2 through 
decreasing the expression of TLR2, decrease lung index 
and improve pathological change[5]. On the basis of related 
studies, we illustrated the advantages of Haoqinqingdan 
decoction in treating this disease and its role in regulating 
immunity through the comparison between the high, medium 
and low dose Haoqinqingdan decoction groups and the 
ribavirin group, which would provide basis for differential 
traditional Chinese medicine treatment of upper respiratory 
viral infection[6].  
2. Materials and methods
2.1. Experimental materials
  Experimental animals and strains: 60 Wistar rats in SPF 
grade with the weight of 180-200 g; the influenza virus A1 
(H1N1) FM1 strains were provided by the National Institute 
for the Control of Pharmaceutical and Biological Products).
Medicine: Haoqinqngdan decoction. Composition: 10 g 
Artemisia annua L, 15 g baical skullcap root, 6 g tangerine 
peel, 10 g rhizoma Pinelliae praeparatum, 10 g Fructus 
aurantii, 10 g Bambusae caulis im taeniam, 30 g talcum, 15 g 
Folium isatidis and 6 g Glycyrrhiza uralensis. The decoction 
method referred to the Great Dictionary of TCM formulas. 
The medicine was concentrated to 1 g/mL and saved in the 
refrigerator at 4 曟. Positive control medicine: ribavirin 
purchased from the Department of Pharmacy of Zhengzhou 
Central Hospital.          
 
2.2. Modeling and grouping
 According to the method reported in the study[7], 48 rats 
were randomly divided into 6 groups with 8 rats in each 
group, namely, the normal control group, the damp-heat 
syndrome model group, the high, medium and low dose 
Haoqinqngdan decoction groups (the high, medium and low 
dose groups for short) and the ribavirin group. The modeling 
started after 1d adaptive feeding. The modeling groups 
were raised by high-fat diet every day, while the normal 
group was given normal diet. On the tenth day of modeling, 
the rats in the modeling groups were infected by the H1N1 
virus through nasal drip. 24 h after viral infection, the rats 
in modeling groups were put into the artificial temperature 
chamber at (32依0.5) 曟, 55%-60% air humidity for 3 h. These 
rats were exposed in this environment for 3h every other day 
with a total heat exposure for three times. The normal control 
group and modeling group were raised separately. The body 
weight and temperature of rats were measured at 9 am every 
day after modeling. 
  On the 17th day after modeling, intragastric administration 
once a day was performed for each treatment group 
(high, medium and low dose groups and ribavirin group). 
The dosage of Haoqinqingdan decoction was calculated 
according to the body surface area of human and rat. The 
doses of high, medium and low groups were 36.92 mg/
kg/d, 18.46 mg/kg/d and 9.23 mg/kg/d, respectively. The 
ribavirin dose was 70 mg/kg/d. The normal control group 
and damp-heat syndrome model group were intragastrically 
administrated by normal saline.      
2.3. Detection of T cell subgroup and cytokine level of rats in 
each group
  After medication for 6 d, eyeballs were extracted for 
blood, and food and water were prohibited 4 h before the 
blood extraction. A total of 0.5 mL blood was added into 
the anticoagulant tube and fully mixed. Detection of T 
lymphocyte subgroup was finished in the same day. The 
serum was separated after blood standing and then was used 
for cytokine detection. 
  Detection of T lymphocyte subgroup: 0.5 mL heart blood 
was taken from the rats. The number and percentage of each 
T lymphocyte subgroup was measured by flow cytometry 
using three kinds of antibodies labeled by different 
fluorescent dyes. The operative procedures were strictly in 
accordance with the instruction. 
  Detection of the cytokine level (IFN-毭/IL-4): about 1mL 
supernatant was taken from rats. Double-antibody sandwich 
ELISA method was used to detect the concentration of 
cytokine. The curve was drawn using the concentration of 
the standard preparation as the X-axis and OD value as the 
Y-axis. The concentration of the specimen can be found in 
the curve by its OD value. IL-4/IFN-毭 = concentration in 
the standard curve 暳dilution multiple. 
2.4. Statistics analysis 
 ANOVA and t test were used for experimental data. Multi-
group comparisons used One-Way ANOVA. Results were 
considered to be statistically significant when P<0.05. SPSS 
16.0 software was used for statistical analysis.      
3. Results
3.1. Temperature and weight changes of rats in each group 
after modeling 
  From the first day to the 14th day after modeling, the 
weight of rats in each experimental group and control group 
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increased significantly (P<0.01), but the rat weight difference 
among groups was not significant at the same time (P>0.05). 
Changes of body temperature: From the first day to the 14th 
day after modeling, the temperature change of the control 
group was not significant (P>0.05), but the rat temperature of 
the modeling groups (the damp-heat syndrome model group, 
the Haoqinqingdan decoction groups and the ribavirin group) 
showed the trend of increasing (P<0.01), and the temperature 
comparison at the same time showed that the temperature of 
rats in the modeling groups was significantly higher than in 
the control group on the 14th day of modeling (P<0.05, Table 
1, 2).
 
3.2. Temperature and weight changes of rats in each group 
after treatment
  The 17th day after modeling was regarded as the first day 
of treatment. The intragastric administration was given 
Table 1
Body weight changes of rats in each group after modeling ( mean暲SD, g).
Group 1 d 7 d 10 d 14 d F P
Control 192.4暲9.1 248.8暲7.6 260.6暲6.5 279.8暲8.5 177.3 0.00
Damp-heat syndrome model 197.5暲9.0 252.7暲10.5 267.3暲7.8 270.7暲6.5 126.2 0.00
High dose group 191.4暲11.3 247.8暲6.7 264.2暲5.8 268.1暲7.8 108.5 0.00
Medium dose group 196.7暲8.6 254.1暲10.0 270.6暲8.3 272.3暲7.1 115.4 0.00
Low dose group 187.8暲8.2 246.4暲8.2 263.1暲9.0 266.4暲8.3 120.9 0.00
Ribavirin 190.6暲7.4 250.3暲7.9 268.9暲8.2 271.6暲9.7 132.7 0.00
F 0.7 0.2 1.1 1.2
P 0.60 0.91 0.40 0.24
Table 2 
Temperature changes of rats in each group after modeling ( mean暲SD, 曟).
Group 1 d 7 d 10 d 14 d F P
Control 37.7暲0.2 37.6暲0.3 37.8暲0.2 37.8暲0.3 0.6 0.62
Damp-heat syndrome model 37.8暲0.2 37.9暲0.3 38.3暲0.4 38.9暲0.5 5.9 0.02
High dose group 37.8暲0.3 38.0暲0.3 38.3暲0.5 39.0暲0.5 4.8 0.03
Medium dose group 37.7暲0.3 37.9暲0.4 38.2暲0.4 39.0暲0.4 7.0 0.01
Low dose group 37.9暲0.4 38.1暲0.3 38.5暲0.3 39.2暲0.5 7.1 0.01
Ribavirin 37.8暲0.4 38.0暲0.3 38.4暲0.4 39.1暲0.4 7.0 0.01
F 0.6 1.5 1.6 6.0
P 0.62 0.29 0.27 0.02
Table 3 
Weight changes of rats in each group after treatment ( mean暲SD, g).
Group 1 d 2 d 3 d 4 d 5 d 6 d F P
Control 287.6暲7.3 293.8暲9.0 299.4暲8.1 302.5暲7.8 304.4暲6.8 307.8暲9.2 3.5 0.04
Damp-heat syndrome model 271.1暲8.5 270.0暲8.3 269.0暲8.8 267.5暲9.0 267.9暲10.2 268.1暲9.7 0.1 0.98
High dose group 268.0暲7.8 269.5暲7.9 270.8暲8.3 271.9暲7.3 272.8暲8.4 274暲6.8 0.2 0.94
Medium dose group 271.6暲8.1 272.1暲8.2 272.9暲7.5 273.3暲8.3 273.6暲8.4 274.2暲8.7 0.3 0.91
Low dose group 267.5暲8.5 267.8暲8.0 270.2暲8.9 270.8暲8.8 271.5暲9.0 272.0暲8.9 0.2 0.97
Ribavirin 271.9暲6.9 272.0暲7.2 272.2暲7.3 272.3暲6.8 272.5暲7.1 272.9暲7.4 0.2 0.97
F 2.5 4.1 5.9 7.5 7.9 8.7
P 0.09 0.02 <0.01 <0.01 <0.01 <0.01
Table 4 
Temperature changes of rats in each group after treatment ( mean暲SD, 曟).
Group 1 d 2 d 3 d 4 d 5 d 6 d F P
Control 37.7暲0.3 37.6暲0.5 37.8暲0.5 37.9暲0.6 37.8暲0.4 37.8暲0.5 0.2 0.98
Damp-heat syndrome model 38.8暲0.4 38.9暲0.4 39.0暲0.6 39.2暲0.5 38.9暲0.5 38.8暲0.6 0.4 0.80
High dose group 39.0暲0.3 38.8暲0.5 38.6暲0.4 38.3暲0.6 38.1暲0.5 37.8暲0.4 3.7 0.03
Medium dose group 39.1暲0.5 38.9暲0.4 38.8暲0.6 38.7暲0.4 38.5暲0.6 38.1暲0.5 3.5 0.04
Low dose group 39.2暲0.3 39.1暲0.5 38.9暲0.4 38.9暲0.5 38.7暲0.6 38.5暲0.5 1.2 0.38
Ribavirin 38.9暲0.4 38.9暲0.5 38.8暲0.5 38.7暲0.3 38.7暲0.3 38.6暲0.4 0.5 0.76
F 7.3 3.8 2.7 3.2 2.2 3.2
P <0.01 0.03 0.08 0.04 0.12 0.04
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to the Haoqinqingdan decoction group and the ribavirin 
group, while the normal control group and the damp-heat 
syndrome model group were intragastricly administrated by 
normal saline. The results indicated that the weight of rats 
in each modeling group slowly increased, but not obviously. 
The group comparison indicated that from the second day 
of treatment, the weight difference among each group was 
significant, and the body weight of rats in the control group 
was obviously higher than in the modeling groups (P<0.05 or 
0.01). With the advances of treatment, obvious temperature 
decrease can only be observed in the medium and high dose 
Haoqinqingdan decoction groups (P<0.05, Table 3, 4).
 
3.3. Comparison of T lymphocyte subgroup and IFN-毭/ 
IL-4 level
  After treatment for 6 days, the CD3+CD4+ percentage and 
CD4
+/CD8+ ratio in the damp-heat syndrome model obviously 
decreased compared with the normal control group, but 




+ percentage and decreased CD4+/CD8+ ratio can be 
observed in the low dose group and ribavirin group (P<0.05). 
Moreover, the CD3+CD4+ percentage of the ribavirin group 
was lower than in the control group (P<0.05, Table 5). The 
IFN-毭 and IFN-毭/IL-4 levels in the peripheral blood of 
rats in the damp-heat syndrome model was obviously higher 
than in the control group (P<0.05, Table 6).
Table 5
Comparison of T lymphocyte subgroup in each group (mean依SD).
Group CD3+CD4+ (%) CD3+CD8+ (%) CD4+/CD8+
Control 75.0依1.7 24.1依1.3 3.1依0.4
Damp-heat syndrome model 62.5依4.1吤 28.2依2.3* 2.2依0.2吤
High dose group 74.5依2.6 24.5依2.1 3.0依0.3
Medium dose group 73.9依2.5 24.9依1.9 2.9依0.3
Low dose group 73.0依3.1 25.4依3.7* 2.8依0.4*
Ribavirin 72.8依4.3* 25.6依3.0* 2.8依0.2*
吤: Compared with the control group, P<0.01; *: Compared with the 
control group, P<0.05.
Table 6
Comparison of Th1/Th2 level in each group(mean依SD).
Group IFN-毭 (ng/L) IL-4 (ng/L) IFN-毭/IL-4
Control 7 454.3依328.9 3 695.8依328.5 2.0
Damp-heat syndrome model 7 996.3依156.4* 3 506.2依187.9 2.3*
High dose group 7 505.8依286.7 3 490.8依217.3 2.1
Medium dose group 7 497.4依202.8 3 517.9依231.7 2.1
Low dose group 7 488.5依227.0 3 548.6依184.6 2.1
Ribavirin 7 483.6依226.5 3 601.4依198.2 2.0
*: Compared with the control group, P<0.05.
4. Discussion
   In modern medicine, respirovirus is a kind of virus 
invading into the human body through respiratory tract and 
causing respiratory tract and/or systemic infection. In most 
circumstances, this kind of virus would infect host cell 
and induce immune response after entering human body 
through respiratory tract[8]. Due to the high mutation rate, 
this kind of virus (such as influenza virus, parainfluenze 
virus, coronavirus and some enteric viruses) often brings 
great difficulty to clinical diagnosis and treatment in clinical 
practice[9,10]. The treatment of this kind of virus is mainly 
symptomatic treatment in modern medicine. Despite of the 
occurrence of many broad-spectrum antivirus agents and 
vaccine, this kind of infection can hardly be radically cured 
for the high variability and drug resistance of virus[11-14]. In 
the treatment of these diseases, traditional Chinese medicine 
focuses on the relationship between virus, organism and 
medicine rather than the virus itself.     
  Respiratory viral infection and its pathogenesis are 
closely related to the immune state of organism. This kind 
of infection belongs to the damp-heat febrile disease, 
because its clinical manifestation and occurrence season 
and region are very similar to the defensive qi & body 
surface and qiphase syndrome of febrile disease[15]. Having 
the function of Qingdan dampness, and regulating stomach 
and dissipating phlegm, Haoqinqingdan decoction is a 
representative prescription for clearing heat and eliminating 
dampness. Febrile disease theory holds that clearing 
heat and eliminating dampness method has the function 
of guiding qi downward, activating spleen, regulating 
stomach, promoting diuresis, clearing heat and dissipating 
dampness, which is suitable for damp-heat febrile 
disease[16]. The experimental results of our study indicated 
that Haoqinqingdan decoction can reverse the decline 
tendency of CD4+/CD8+ ratio caused by the synthetic action 
of damp-heat environment and viral infection, making the 
CD4
+/CD8+ ratio close to the normal control group. In the 
comparison of Th1/Th2 cytokine (IFN-毭/IL-4) level, after 
treated by Haoqinqingdan decoction for 6 days, the IFN-
毭 and IFN-毭/IL-4 levels in the peripheral blood of rats in 
the damp-heat syndrome model group was obviously higher 
than in the control group, while the IFN-毭/IL-4 levels of 
the other modeling groups were close to the control group. 
These results indicated that Haoqinqingdan decoction 
can strengthen the effect of rat helper T cell, regulate the 
balance of T lymphocyte subsets and the balance of Th1/
Th2 and strengthen the anti-virus immune function of 
organism[7], and the efficacy of high dose drugs was lower 
than the low dose. The possible mechanism of the antiviral 
immune injury of Haoqinqingdan decoction is up-regulating 
cellular immune function, re-balancing the CD4+/CD8+ and 
Th1/Th2 and lightening the stress state[17].               
  In the improvement of rat temperature, obvious decline 
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of temperature can only be observed in the medium and 
high dose Haoqinqingdan decoction groups (P<0.05), and 
the effect of decreasing rat temperature was not obvious in 
low dose Haoqinqingdan decoction group and the ribavirin 
group (P>0.05), which indicated that the therapeutic effect 
of Haoqinqingdan decoction on fever caused by influenza 
virus was notable[18-20]. In the aspect of weight, although 
the immune state and temperature of rats in each treatment 
group were improved, the body weight did not significantly 
increase after treatment (P>0.05). This indicated that damp-
heat syndrome had great impact on the dietary intake and 
metabolism of rats, and this impact can hardly recovered 
in a short time. It was also found that in regulation of 
the balance of T cell subset (CD4+/CD8+), the therapeutic 
effect of ribavirin was poorer than the medium and high 
dose Haoqinqingdan decoction, but was close to the low 
dose Haoqinqingdan decoction, which indicated that 
ribavirin has a certain effect on the treatment of damp-heat 
syndrome caused by influenza virus, but is not superior to 
Haoqinqingdan decoction. 
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